HEM.V - Hemostemix Inc.

TSXV - TSXV Delayed Price. Currency in CAD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development2,263.94460.262178.6431,490.861
Selling General and Administrative2,523.0122,295.7062,435.2642,453.965
Non Recurring----
Others----
Total Operating Expenses6,423.0992,810.2292,613.9073,981.703
Operating Income or Loss-6,423.099-2,810.229-2,613.907-3,981.703
Income from Continuing Operations
Total Other Income/Expenses Net241.636-700.763-142.21519.384
Earnings Before Interest and Taxes-6,423.099-2,810.229-2,613.907-3,981.703
Interest Expense--1,138.82-76.737-3.565
Income Before Tax-6,181.463-3,510.992-2,756.122-3,962.319
Income Tax Expense--60.155-26.0322.749
Minority Interest----
Net Income From Continuing Ops-6,181.463-3,450.837-2,730.092-3,985.068
Non-recurring Events
Discontinued Operations-6.222-484.074-1,054.42-1,054.42
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-6,187.685-3,934.911-3,784.512-3,985.068
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-6,187.685-3,934.911-3,784.512-3,985.068